Scholar Rock prices at-the-market offering of up to $200M of common stock at market prices

Filed August 6, 2026 · ~2 min read

Key Changes

• high

  At-the-market offering of up to $200M of common stock sold over time at varying market prices; approximately 4.4M shares at the $45.85 reference price (August 3, 2026 close), all primary shares with proceeds to the company.

  The Offering verify on EDGAR →
• high

  Implied post-offering market capitalization of $5.8B at the $45.85 reference price (125,962,446 shares outstanding after the offering).

  The Offering verify on EDGAR →
• high

  Proceeds for apitegromab commercialization (commercial infrastructure and supply chain buildout), clinical programs, platform development, and general corporate purposes; management retains broad discretion over allocation.

  Use of Proceeds verify on EDGAR →